Periprosthetic joint infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age =18 years old, gender is not limited; (2) The experimental group met the diagnostic criteria of chronic periprosthesis infection after joint replacement according to the 2018 Musculoskeletal Infection Association; The control group was eligible for primary replacement patients who excluded periprosthesis infection. (3) Voluntary and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with immune-related arthritis such as rheumatoid and rheumatism were excluded; (2) Radiotherapy and chemotherapy are required due to neoplastic diseases; (3) Receiving systemic glucocorticoid therapy (prednisone > 10mg/ day or equivalent hormone medication); (4) Severe immunodeficiency diseases (such as stage 3 HIV, sickle cell anemia, splenectomy, etc.); (5) Have a history of drug abuse; (6) Use immunosuppressive drugs to treat bone marrow or other transplants; (7) Pregnant, parturient and lactating women; (8) Participating in other clinical trials; (9) Researchers consider other reasons not appropriate for clinical trial participants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Joint fluid target protein detection; | — |
Secondary
| Measure | Time frame |
|---|---|
| X-ray;Hip and knee function score;Liver function;Kidney function;Erythrocyte sedimentation rate (ESR);C-reactive protein (CRP);Synovial fluid white blood cell count (WBC);Synovial fluid polymorphycyte neuclear cell (PMN)%;Doppler lower extremity vascular color ultrasound;Infection control rate;Time between infection recurrence;Re-operation rate;Type of antibiotic; | — |
Countries
China
Contacts
Department of Joint Surgery, The First Affiliated Hospital, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, People 's Republic of China